Skip the complicated regimens and expensive products seen on social media. The science of skin is deep but the ...

Nu Skin Enterprises trades at a deep value multiple (~3x 2026 EBITDA) but faces persistent core business decline and unproven turnaround catalysts. Guidance disappointed, yet management expects margin ...

Nu Skin is rated a buy, trading at low multiples with turnaround prospects tied to India expansion and Prysm iO device launch. NUS’s core MLM business faces structural decline, but new product and ...

Psoriasis is a chronic inflammatory skin condition that speeds up skin cell turnover, leading to thick, scaly patches on the skin. These plaques can develop all over the body, including the arms, legs ...

Aristotle Capital Boston, LLC, an investment advisor, released its fourth-quarter investor letter for “Small Cap Equity Fund”. A copy of the letter can be downloaded here. U.S. small-cap equities ...

Shares of Nu Skin Enterprises were lower after the company reported lower revenue in the fourth quarter and guided for further declines, despite swinging to a profit. Shares were down 17% at $8.45 in ...

Ryan S. Napierski. Thanks, B.G. Good afternoon, everyone. Thanks for joining the call. I am pleased to report that we delivered fourth quarter and 2025 results within our guidance range with a strong ...

PROVO, Utah (AP) — PROVO, Utah (AP) — Nu Skin Enterprises Inc. (NUS) on Thursday reported net income of $14.5 million in its fourth quarter. The Provo, Utah-based company said it had profit of 29 ...

Eight is definitely someone’s lucky number—especially when a few zeros are tacked on at the end. The top-floor unit of the 80-story 80 Columbus Circle in Manhattan is coming to market for the first ...